Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Anti-alpha-actinin Antibodies and Lupus Nephritis Activity

View source ↗

Summary

Assiut University is conducting a clinical trial to evaluate anti-alpha-actinin antibodies for lupus nephritis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anti-alpha-actinin antibodies (anti-alpha-actinin antibody)

Snippet

Sponsor: Assiut University | Conditions: Lupus Nephritis | Status: NOT_YET_RECRUITING